Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/34810
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAktaş, Nimet-
dc.date.accessioned2023-11-09T06:21:49Z-
dc.date.available2023-11-09T06:21:49Z-
dc.date.issued2018-
dc.identifier.citationOruç, A. vd. (2018). ''Hepatotoxicity associated with eculizumab in a patient with atypical hemolytic uremic syndrome''. Nefrologia, 38(4), 448-450.en_US
dc.identifier.issn0211-6995-
dc.identifier.issn1989-2284-
dc.identifier.urihttps://doi.org/10.1016/j.nefroe.2018.04.004-
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S2013251418300622-
dc.identifier.urihttp://hdl.handle.net/11452/34810-
dc.language.isoenen_US
dc.publisherSoc Espanola Nefrologia Dr Rafael Matesanzfre
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAtıf Gayri Ticari Türetilemez 4.0 Uluslararasıtr_TR
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectUrology & nephrologyen_US
dc.subjectComplement inhibitor eculizumaben_US
dc.subject.meshAdulten_US
dc.subject.meshAntibodies, monoclonal, humanizeden_US
dc.subject.meshAtypical hemolytic uremic syndromeen_US
dc.subject.meshChemical and drug induced liver injuryen_US
dc.subject.meshHumansen_US
dc.subject.meshMaleen_US
dc.titleHepatotoxicity associated with eculizumab in a patient with atypical hemolytic uremic syndromeen_US
dc.title.alternativeHepatotoxicidad asociada con eculizumab en un paciente con síndrome urémico hemolítico atípicofre
dc.typeLetteren_US
dc.identifier.wos000439099700019tr_TR
dc.identifier.scopus2-s2.0-85049994526tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/ İç Hastalıkları Anabilim Dalı/Nefroloji Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0002-0342-9692tr_TR
dc.contributor.orcid0000-0003-4607-9220tr_TR
dc.identifier.startpage448tr_TR
dc.identifier.endpage450tr_TR
dc.identifier.volume38tr_TR
dc.identifier.issue4tr_TR
dc.relation.journalNefrologiaen_US
dc.contributor.buuauthorOruç, Ayşegül-
dc.contributor.buuauthorAyar, Yavuz-
dc.contributor.buuauthorVuruşkan, Berna Aytaç-
dc.contributor.buuauthorYıldız, Abdülmecit-
dc.contributor.buuauthorYavuz, Mahmut-
dc.contributor.buuauthorGüllülü, Mustafa-
dc.contributor.buuauthorDilek, Kamil-
dc.contributor.buuauthorErsoy, Alparslan-
dc.contributor.researcheridAAH-4002-2021tr_TR
dc.contributor.researcheridO-9948-2015tr_TR
dc.contributor.researcheridAAH-9746-2021tr_TR
dc.contributor.researcheridAGF-0767-2022tr_TR
dc.contributor.researcheridGSE-0029-2022tr_TR
dc.relation.collaborationSanayitr_TR
dc.identifier.pubmed29221881tr_TR
dc.subject.wosUrology & nephrologyen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubMeden_US
dc.wos.quartileQ4en_US
dc.contributor.scopusid55133912100tr_TR
dc.contributor.scopusid55860143300tr_TR
dc.contributor.scopusid56527372000tr_TR
dc.contributor.scopusid56256977500tr_TR
dc.contributor.scopusid7006244754tr_TR
dc.contributor.scopusid6602684544tr_TR
dc.contributor.scopusid56005080200tr_TR
dc.contributor.scopusid35612977100tr_TR
dc.subject.emtreeAminotransferaseen_US
dc.subject.emtreeAmlodipineen_US
dc.subject.emtreeCarvedilolen_US
dc.subject.emtreeCreatinineen_US
dc.subject.emtreeEculizumaben_US
dc.subject.emtreeLactate dehydrogenaseen_US
dc.subject.emtreeMethyldopaen_US
dc.subject.emtreeRamiprilen_US
dc.subject.emtreeEculizumaben_US
dc.subject.emtreeMonoclonal antibodyen_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeBlood pressure regulationen_US
dc.subject.emtreeBlood smearen_US
dc.subject.emtreeCase reporten_US
dc.subject.emtreeClinical articleen_US
dc.subject.emtreeCreatinine blood levelen_US
dc.subject.emtreeDisease classificationen_US
dc.subject.emtreeDrug withdrawalen_US
dc.subject.emtreeEchographyen_US
dc.subject.emtreeFatty liveren_US
dc.subject.emtreeHeadacheen_US
dc.subject.emtreeHemolytic uremic syndromeen_US
dc.subject.emtreeHepatomegalyen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeHuman cellen_US
dc.subject.emtreeHuman tissueen_US
dc.subject.emtreeHypertension retinopathyen_US
dc.subject.emtreeKidney biopsyen_US
dc.subject.emtreeLaboratory testen_US
dc.subject.emtreeLactate dehydrogenase blood levelen_US
dc.subject.emtreeLetteren_US
dc.subject.emtreeLiver toxicityen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreePhysical examinationen_US
dc.subject.emtreePlasma exchangeen_US
dc.subject.emtreeThrombocytopeniaen_US
dc.subject.emtreeThrombotic thrombocytopenic purpuraen_US
dc.subject.emtreeTreatment durationen_US
dc.subject.emtreeComplicationen_US
dc.subject.emtreeHemolytic uremic syndromeen_US
dc.subject.emtreeToxic hepatitisen_US
Appears in Collections:Scopus
Web of Science

Files in This Item:
File Description SizeFormat 
Oruç_vd_2018.pdf540.59 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons